|
PHKA1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.52239999495762E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.589800E-04 |
| Normal-vs-Stage2 |
1.097960E-02 |
| Normal-vs-Stage3 |
1.193600E-04 |
| Normal-vs-Stage4 |
1.962600E-03 |
| Stage1-vs-Stage2 |
6.626000E-01 |
| Stage1-vs-Stage3 |
7.434200E-01 |
| Stage1-vs-Stage4 |
8.402000E-01 |
| Stage2-vs-Stage3 |
8.617600E-01 |
| Stage2-vs-Stage4 |
8.166800E-01 |
| Stage3-vs-Stage4 |
9.244400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.01260000279413E-08 |
| Normal-vs-AfricanAmerican |
2.256100E-02 |
| Normal-vs-Asian |
1.129240E-01 |
| Caucasian-vs-AfricanAmerican |
1.089650E-01 |
| Caucasian-vs-Asian |
7.953200E-01 |
| AfricanAmerican-vs-Asian |
2.094000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.80739999972235E-07 |
| Normal-vs-Female |
3.844400E-04 |
| Male-vs-Female |
1.351650E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.057020E-01 |
| Normal-vs-Age(41-60Yrs) |
2.32489999999475E-05 |
| Normal-vs-Age(61-80Yrs) |
1.200830E-04 |
| Normal-vs-Age(81-100Yrs) |
1.864580E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.050200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.902000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.906200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.020200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.974400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.496630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.674800E-01 |
| Normal-vs-Grade 2 |
1.434710E-04 |
| Normal-vs-Grade 3 |
5.381500E-04 |
| Normal-vs-Grade 4 |
1.400240E-03 |
| Grade 1-vs-Grade 2 |
7.232600E-01 |
| Grade 1-vs-Grade 3 |
8.818000E-01 |
| Grade 1-vs-Grade 4 |
8.431800E-01 |
| Grade 2-vs-Grade 3 |
2.641200E-01 |
| Grade 2-vs-Grade 4 |
3.834600E-01 |
| Grade 3-vs-Grade 4 |
8.246800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.580170E-02 |
| Normal-vs-ccB subtype |
4.59119997575641E-09 |
| ccA subtype-vs-ccB subtype |
2.24500000000072E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.68679999862565E-08 |
| Normal-vs-N1 |
2.629000E-01 |
| N0-vs-N1 |
5.962600E-01 |
|
|
